follitropin alfa
Selected indexed studies
- Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development. (Drug Saf, 2019) [PMID:30341677]
- Lutropin alfa. (Drugs, 2008) [PMID:18627209]
- Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies. (BioDrugs, 2009) [PMID:19344190]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Lutropin alfa. (2008) pubmed
- Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development. (2019) pubmed
- Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies. (2009) pubmed
- Improving the consistency of ovarian stimulation: follitropin alfa filled-by-mass. (2006) pubmed
- Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients. (2006) pubmed
- Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley rats. (2008) pubmed
- Lutropin alfa: new preparation. Combined with follitropin for follicular development: no better than menotropin. (2003) pubmed
- Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study. (2010) pubmed
- A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology. (2014) pubmed
- Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. (2009) pubmed